Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Combination of Hydroxyurea and Low-dose Thalidomide on Hemoglobin Synthesis in Thalassemia Patients

NCT05132270 is registered in ClinicalTrials.gov with Children's Hospital Karachi as lead sponsor.

NCT NCT05132270
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05132270 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Combination of Hydroxyurea and Low-dose Thalidomide on Hemoglobin Synthesis in Thalassemia Patients
Lead sponsor
Children's Hospital Karachi
Phase
Phase 2/3
Overall status
Completed
Start date
January 1, 2020
Completion date
January 31, 2021
Enrollment
135 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thalassemia, beta